413 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Original Article
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status
Ali JN Duabil ... George DD Jones
Published: December 21, 2023 Explor Target Antitumor Ther. 2023;4:1210–1226
5544 36 1
Open Access Original Article
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer
Vignesh Sivaganesh, Bela Peethambaran
Published: December 20, 2023 Explor Target Antitumor Ther. 2023;4:1188–1209
5020 41 10
Open Access Case Report
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Sviatoslav Chekhun ... Maria Saigí
Published: December 13, 2023 Explor Target Antitumor Ther. 2023;4:1182–1187
4277 21 0
Open Access Review
Targeting cancer stem cell plasticity in triple-negative breast cancer
Zhengwang Guo, Shuyan Han
Published: December 11, 2023 Explor Target Antitumor Ther. 2023;4:1165–1181
This article belongs to the special issue Innovative Strategies to Target Triple-negative Breast Cancer
8136 68 15
Open Access Case Report
Unexpected “Lazarus response” to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer
Alexey V. Emshanov ... Evgeny N. Imyanitov
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1157–1164
3712 25 1
Open Access Original Article
Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy
Witida Laopajon ... Watchara Kasinrerk
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1145–1156
This article belongs to the special issue Novel Strategies and Targets for Immunotherapy of Cancer
5826 38 0
Open Access Meta-Analysis
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis
Marco Filetti ... Gennaro Daniele
Published: December 01, 2023 Explor Target Antitumor Ther. 2023;4:1136–1144
4280 74 3
Open Access Commentary
A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?
Dimitrios Bouzianas, Stella Bouziana
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1128–1135
This article belongs to the special issue Novel Strategies and Targets for Immunotherapy of Cancer
6988 25 2
Open Access Perspective
Cholesterol esterification and p53-mediated tumor suppression
Youjun Li ... Edward V. Prochownik
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1122–1127
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
5544 33 3
Open Access Original Article
Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression
Levi Arnold ... Sufi Mary Thomas
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1104–1121
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
5170 94 3
Open Access Systematic Review
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
Veronica Agostinelli ... Rossana Berardi
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1095–1103
This article belongs to the special issue COVID-19 and Cancer
3981 19 0
Open Access Review
Coronavirus disease 2019 and lung cancer: where are we?
Abrahams Ocanto ... Felipe Couñago
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1082–1094
This article belongs to the special issue COVID-19 and Cancer
4851 18 2
Open Access Review
Overcoming phenotypic switching: targeting protein-protein interactions in cancer
Christos Ladias ... Nikolaos A. Papanikolaou
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1071–1081
This article belongs to the special issue Off-Label Drugs and -Omics Data in Cancer Treatment
7064 40 1
Open Access Original Article
Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique
Marzieh Tahmasebi ... Amir Jamshidnezhad
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1059–1070
4313 29 2
Open Access Systematic Review
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review
Afrooz Mazidimoradi ... Hamid Salehiniya
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1039–1058
This article belongs to the special issue COVID-19 and Cancer
4109 16 2
Open Access Review
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton ... Barbara Rath
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1027–1038
This article belongs to the special issue Integrated Approaches for Non-Small-Cell Lung Cancer
6970 24 3
Open Access Review
A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors
Babak Sokouti
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:994–1026
6570 55 2
Open Access Review
Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses
George Anderson
Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:962–993
9152 48 20
Open Access Review
Biomarkers in renal cell carcinoma and their targeted therapies: a review
Shruti Gupta, Shamsher Singh Kanwar
Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:941–961
10045 53 17
Open Access Systematic Review
Current role of artificial intelligence in head and neck cancer surgery: a systematic review of literature
Antonella Loperfido ... Gianluca Bellocchi
Published: October 24, 2023 Explor Target Antitumor Ther. 2023;4:933–940
This article belongs to the special issue Artificial Intelligence for Precision Oncology
6299 63 19